NCT07711782

Brief Summary

Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 18, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 18, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

2 months

First QC Date

July 13, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

Kefir waterpoly cystic ovarian syndromereproductive health

Outcome Measures

Primary Outcomes (1)

  • Lipid Profile

    Blood lipid profile were obtained using fasting blood samples to determine serum total cholesterol, high-density lipoprotein cholesterol (HD L-C), low density lipoprotein cholesterol (LDL-C) and triglycerides.

    8 weeks

Secondary Outcomes (2)

  • FSH (follicle stimulating hormone)

    8 weeks

  • LH (luteinizing hormone)

    8 weeks

Other Outcomes (1)

  • TSH (Thyroid stimulating hormone test)

    8 weeks

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Calorie deficit diet plan

Other: (C0) Control group

Experimental Group

EXPERIMENTAL

Diet plan + 250ml kefir water

Dietary Supplement: (G1) Experimental group

Interventions

Participants were subjected to use a regular calorie deficit diet plan

Control Group
(G1) Experimental groupDIETARY_SUPPLEMENT

Participants were advised to take water 250ml of water kefir per day in their mid-morning snack time for 2 months.

Experimental Group

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Females of age 18-25 will be selected.
  • Females suffering from amenorrhea or cycle longer then 35days were selected.
  • Females with PCOS were selected.
  • Females with BMI 18.5-29.9 were selected in this research.
  • Females with thyroid issues were selected.

You may not qualify if:

  • Pregnant and breast-feeding females were not included.
  • Those who smoke were not included.
  • Those who consume alcohol were not included.
  • Those suffering from endocrine diseases were not be included.
  • Those taking lipid- lowering drugs or blood pressure regulating medications were not be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Lahore

Lahore, Pakistan

Location

Related Links

MeSH Terms

Conditions

Polycystic Ovary Syndrome

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Ovarian CystsCystsNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesGonadal DisordersEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Head UIDNS

Study Record Dates

First Submitted

July 13, 2026

First Posted

July 17, 2026

Study Start

January 18, 2026

Primary Completion

March 18, 2026

Study Completion

April 18, 2026

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

Locations